271 related articles for article (PubMed ID: 31413178)
21. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.
Jiang A; Gao H; Kelley MR; Qiao X
Vision Res; 2011 Jan; 51(1):93-100. PubMed ID: 20937296
[TBL] [Abstract][Full Text] [Related]
23. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration.
Zou GM; Maitra A
Mol Cancer Ther; 2008 Jul; 7(7):2012-21. PubMed ID: 18645011
[TBL] [Abstract][Full Text] [Related]
24. APE1/Ref-1 prevents oxidative inactivation of ERK for G1-to-S progression following lead acetate exposure.
Wang YT; Tzeng DW; Wang CY; Hong JY; Yang JL
Toxicology; 2013 Mar; 305():120-9. PubMed ID: 23370007
[TBL] [Abstract][Full Text] [Related]
25. The redox function of apurinic/apyrimidinic endonuclease 1 as key modulator in photodynamic therapy.
Franchi LP; de Freitas Lima JEB; Piva HL; Tedesco AC
J Photochem Photobiol B; 2020 Oct; 211():111992. PubMed ID: 32805556
[TBL] [Abstract][Full Text] [Related]
26. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
[TBL] [Abstract][Full Text] [Related]
27. APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.
Shin JH; Choi S; Lee YR; Park MS; Na YG; Irani K; Lee SD; Park JB; Kim JM; Lim JS; Jeon BH
Cancer Res Treat; 2015 Oct; 47(4):823-33. PubMed ID: 25672588
[TBL] [Abstract][Full Text] [Related]
28. Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function.
Vascotto C; Bisetto E; Li M; Zeef LA; D'Ambrosio C; Domenis R; Comelli M; Delneri D; Scaloni A; Altieri F; Mavelli I; Quadrifoglio F; Kelley MR; Tell G
Mol Biol Cell; 2011 Oct; 22(20):3887-901. PubMed ID: 21865600
[TBL] [Abstract][Full Text] [Related]
29. NMR studies reveal an unexpected binding site for a redox inhibitor of AP endonuclease 1.
Manvilla BA; Wauchope O; Seley-Radtke KL; Drohat AC
Biochemistry; 2011 Dec; 50(48):10540-9. PubMed ID: 22032234
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor.
Qian C; Li M; Sui J; Ren T; Li Z; Zhang L; Zhou L; Cheng Y; Wang D
Drug Des Devel Ther; 2014; 8():485-96. PubMed ID: 24872679
[TBL] [Abstract][Full Text] [Related]
31. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
[TBL] [Abstract][Full Text] [Related]
32. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
[TBL] [Abstract][Full Text] [Related]
33. APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells.
McIlwain DW; Fishel ML; Boos A; Kelley MR; Jerde TJ
Oncotarget; 2018 Feb; 9(13):10962-10977. PubMed ID: 29541389
[TBL] [Abstract][Full Text] [Related]
34. DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
Kaur G; Cholia RP; Mantha AK; Kumar R
J Med Chem; 2014 Dec; 57(24):10241-56. PubMed ID: 25280182
[TBL] [Abstract][Full Text] [Related]
35. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
36. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity.
Ando K; Hirao S; Kabe Y; Ogura Y; Sato I; Yamaguchi Y; Wada T; Handa H
Nucleic Acids Res; 2008 Aug; 36(13):4327-36. PubMed ID: 18586825
[TBL] [Abstract][Full Text] [Related]
37. Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression.
Curtis CD; Thorngren DL; Ziegler YS; Sarkeshik A; Yates JR; Nardulli AM
Mol Endocrinol; 2009 Sep; 23(9):1346-59. PubMed ID: 19460860
[TBL] [Abstract][Full Text] [Related]
38. APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma - characterizing gene expression changes and identifying novel pathways using single-cell RNA sequencing.
Shah F; Goossens E; Atallah NM; Grimard M; Kelley MR; Fishel ML
Mol Oncol; 2017 Dec; 11(12):1711-1732. PubMed ID: 28922540
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis.
Di Maso V; Mediavilla MG; Vascotto C; Lupo F; Baccarani U; Avellini C; Tell G; Tiribelli C; Crocè LS
PLoS One; 2015; 10(12):e0143289. PubMed ID: 26624999
[TBL] [Abstract][Full Text] [Related]
40. Hydrogen peroxide activates APE1/Ref-1 via NF-κB and Parkin: a role in liver cancer resistance to oxidative stress.
Siswanto FM; Okukawa K; Tamura A; Oguro A; Imaoka S
Free Radic Res; 2023 Dec; 57(3):223-238. PubMed ID: 37364176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
